Identification of a chemical that can restore the production of dystrophin in the cells of a Duchene muscular dystrophy patient is reported this week in Nature Communications. These findings may be useful in developing a therapy for some mild forms of Duchenne muscular dystrophy.
In some mild forms of Duchenne muscular dystrophy a small amount of functional protein is produced via exon skipping. Masatoshi Hagiwara and colleagues previously screened a chemical library containing 100,000 chemicals and identified one compound that was associated with exon skipping. They now show that the compound can restore the production of dystophin in an individual patient’s cells.
Although, synthetic DNA molecules have been shown to induce a similar exon skipping of the dystrophin gene, the identification of the chemical may also aid in the treatment of some forms of Duchenne muscular dystrophy.
Zoology: Mineral armour discovered in insectsNature Communications
Neuroscience: Social isolation evokes craving responses in the human brainNature Neuroscience
Ecology: Migration associated with faster pace of lifeNature Communications
Gene therapy: Concerns for the long-term safety of AAV gene therapyNature Biotechnology